This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1CJ Chiu & A Taylor (2007) Nutritional antioxidants and age-related cataract and maculopathy. Exp Eye Res 84, 229–245.
3A Laitinen , L Laatikainen , T Harkanen , (2010) Prevalence of major eye diseases and causes of visual impairment in the adult Finnish population: a nationwide population-based survey. Acta Ophthalmol 88, 463–471.
4Age-Related Eye Disease Study Research Group (2001) Risk factors associated with age-related nuclear and cortical cataract: a case-control study in the Age-Related Eye Disease Study, AREDS Report no. 5. Ophthalmology 108, 1400–1408.
5P Vashist , B Talwar , M Gogoi , (2011) Prevalence of cataract in an older population in India: the India study of age-related eye disease. Ophthalmology 118, 272–278.
6SM Moeller , R Voland , L Tinker , (2008) Associations between age-related nuclear cataract and lutein and zeaxanthin in the diet and serum in the Carotenoids in the Age-Related Eye Disease Study, an ancillary study of the Women's Health Initiative. Arch Ophthalmol 126, 354–364.
8KJ Yeum , FM Shang , WM Schalch , (1999) Fat-soluble nutrient concentrations in different layers of human cataractous lens. Curr Eye Res 19, 502–505.
9JA Mares-Perlman , WE Brady , BE Klein , (1995) Diet and nuclear lens opacities. Am J Epidemiol 141, 322–334.
10PF Jacques , LT Chylack Jr, SE Hankinson , (2001) Long-term nutrient intake and early age-related nuclear lens opacities. Arch Ophthalmol 119, 1009–1019.
11CR Gale , NF Hall , DI Phillips , (2001) Plasma antioxidant vitamins and carotenoids and age-related cataract. Ophthalmology 108, 1992–1998.
12M Dherani , GV Murthy , SK Gupta , (2008) Blood levels of vitamin C, carotenoids and retinol are inversely associated with cataract in a North Indian population. Invest Ophthalmol Vis Sci 49, 3328–3335.
13HT Vu , L Robman , A Hodge , (2006) Lutein and zeaxanthin and the risk of cataract: the Melbourne visual impairment project. Invest Ophthalmol Vis Sci 47, 3783–3786.
14C Delcourt , I Carriere , M Delage , (2006) Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study. Invest Ophthalmol Vis Sci 47, 2329–2335.
20J Karppi , T Nurmi , B Olmedilla-Alonso , (2008) Simultaneous measurement of retinol, alpha-tocopherol and six carotenoids in human plasma by using an isocratic reversed-phase HPLC method. J Chromatogr B Analyt Technol Biomed Life Sci 867, 226–232.
23JA Laukkanen , D Laaksonen , TA Lakka , (2009) Determinants of cardiorespiratory fitness in men aged 42 to 60 years with and without cardiovascular disease. Am J Cardiol 103, 1598–1604.
25E Rodriguez-Rodriguez , RM Ortega , AM Lopez-Sobaler , (2006) The relationship between antioxidant nutrient intake and cataracts in older people. Int J Vitam Nutr Res 76, 359–366.
26FF de Moura , CC Ho , G Getachew , (2005) Kinetics of 14C distribution after tracer dose of 14C-lutein in an adult woman. Lipids 40, 1069–1073.
28PS Bernstein , F Khachik , LS Carvalho , (2001) Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. Exp Eye Res 72, 215–223.
29A Sujak , J Gabrielska , W Grudzinski , (1999) Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: the structural aspects. Arch Biochem Biophys 371, 301–307.
30AA Woodall , G Britton & MJ Jackson (1997) Carotenoids and protection of phospholipids in solution or in liposomes against oxidation by peroxyl radicals: relationship between carotenoid structure and protective ability. Biochim Biophys Acta 1336, 575–586.
31JJ Wang , E Rochtchina , AG Tan , (2009) Use of inhaled and oral corticosteroids and the long-term risk of cataract. Ophthalmology 116, 652–657.
33J Redon , M Oliva , C Tormos , (2003) Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 41, 1096–1101.
34S Furukawa , T Fujita , M Shimabukuro , (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114, 1752–1761.
35NI Krinsky & EJ Johnson (2005) Carotenoid actions and their relation to health and disease. Mol Aspects Med 26, 459–516.